Member Info for leas

Having read today's RNS then I wouldn't say the financials are robust. Admin expenses up, R&D down. In fact more being spent on the latter. Partnerships are pivotal in IMM's success and if Lupuzor does succeed at the P3 stage then I can see a handsome offer to shareholders for the entire rights. Timing is everything lets hope the trial is completed before 2023.
Maybe a few private investors selling today but no drama.

BP.. not BT of course

Gotitwrong
If the share price decline was just BT then you would have to look at the CEO and ask questions. You may argue that Looney is positioning BP for a future of less oil demand towards a company making very good profits from carbon neutral energy.
I read this Reuters article today. I don't think a change at the top will make much difference in the direction of the share price.
https://www.msn.com/en-gb/money/other/oil-extends-losses-as-rising-covid-19-cases-fuel-demand-concerns/ar-BB19ymVP?ocid=msedgntp

This is currently a company with a MC of less than 30m. MM's only purpose is to generate trades as that is their source of income. Institutions wanting to increase their holding or reduce for that matter may ask a MM to get the best price. In turn that may increase or decrease liquidity. No volume here, nothing to concern private investors, just dropping the price to attract trades.
They may do the opposite later and finish up but the RNS has had no bearing on today's price. I think those who have an interest in IMM are already positioned for news which imo will be positive and set out the map for P3. Again only my opinion but I don't think the news will move the sp as high as some expect.

Trades after hours are trades that are not conducted on the regular market but between individuals and executed electronically. It does have a bearing on the opening price. ECN's (Electronic communication networks) are volatile and very risky and liquidity is always a problem. As private investors, its another advantage large institutions have over us although I guess there is nothing preventing us doing the same.

I think if Eva was called Bob then I would guess that anyone couldn’t give 2 fooks :)

aper
Many good companies in dire straits and clearly the problems they face is priced in.

I guess investors are already positioned waiting for the FDA to agree the trial design for Lupuzor.

Hi Andle
Not invested at the moment. Completely out of the market since March. Have to admit, very tempting here.

I have read that the FDA have already stated that due to staff shortages and C-19 being their priority that the timeframes for approval may not be within the PDUFA guidelines. If company's have been advised by the FDA of any delay in approval then they should communicate this to their shareholders.

Mavs, don’t disagree but I think the opening of the US markets will be the bigger influence on the closing price.

Thanks Falky. Post crossed. I'm sure you will be able to buy a lot of real estate when LLOY hits 45+ on a Friday.
Good luck.

Falky. Do you live in the Falklands. Seems like its lovely there every day?

'Lovely morning here. I am happy with my holding in lloyds.' where is here? Surely not the Falklands?

bobG, the supply must be greater than the demand. Simple as...

A broker could be asked to sell a large number of shares on behalf of a client/institution. They will only get anywhere near the bid if there is a demand to buy them. If not they will drop the ask until buyers are tempted.

score
IMM was very good to me but I never intended to hold waiting for the P3 results. I have never in any pharma unless they have a supporting portfolio of revenue producing drugs.
I think at this price it is very tempting and the relatively low number of shares in issue.
IMM almost 10x bagged for me last time but took many years of research and sitting on my hands to see the return.
I am completely out of the markets at the moment and look to making a killing when we are through the current crisis.
IMM is certainly on my watch list though as the potential is starting to outweigh the risks.

I see TUI have released their RNS today on trading going forward and their means of funding. It has helped the share price (to date) recover May be prudent of JET2 to do the same and keep current investors a little happier to hold through the C-19 pandemic.

£1.40p

eva, I think the name is a clue. He has been talking talking talking since the doomed P3 trials of P140 a few years ago. I think he fell for Tim's trap of raising funds at £140 just before the FDA released their findings. Bitter pill for Nolupus to swallow. Of course he will tell investors here that he is all knowing and well researched.. :)

Falky, when the sp was at 36p I posted my reasons on why the sp will be below 25p and why this sector for now should be avoided. You are consistent with your cry of over 45p in 2020 but could you please back up your target price with the reasons supporting that view.
Yes a lot of company's MC took a hit yesterday but LLOY seems to be taking a hit on a frequent basis. Imo, this drop seems very controlled and drawing in private investors as the institutions reduce. There is every possibility that your cry of 45p + may draw in a novice investor which would be a little unfair.